Skip to main content
Equibles

OSAIC HOLDINGS, INC.

Position in EOCN — Galmed Pharmaceuticals Ltd.

CIK 1677044 SCOTTSDALE, AZ
Back to EOCN Full portfolio

Position in EOCN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2
+$2 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 12 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EOCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OSAIC HOLDINGS, INC. holds $240,097,471 across 404 Biotechnology names. EOCN ranks #396 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 90,236 $28,522,697
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,586 $24,630,851
3 TGTX
Tg Therapeutics, Inc.
 372,588 $20,469,983
4 BBIO
BridgeBio Pharma, Inc.
 217,577 $16,205,134
5 HALO
Halozyme Therapeutics, Inc.
 176,973 $13,851,674
6 ALNY
Alnylam Pharmaceuticals, Inc.
 45,298 $13,636,055
7 VCEL
Vericel Corp
 182,038 $8,098,869
8 REGN
Regeneron Pharmaceuticals, Inc.
 12,423 $7,746,234

All Filings in EOCN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2 5
2026-03-31 — 5
2025-12-31 — 5
2025-09-30 — 5
2025-06-30 — 5
2025-03-31 — 5
2024-12-31 — 5
2024-09-30 — 5
2024-06-30 — 53
2024-03-31 — 53
2023-12-31 — 53
2023-09-30 — 53